Kazumasa Goda
Kobe University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kazumasa Goda.
International Journal of Urology | 2006
Nobuyuki Hinata; Toshiro Shirakawa; Shuji Terao; Kazumasa Goda; Kazushi Tanaka; Yuji Yamada; Isao Hara; Sadao Kamidono; Masato Fujisawa; Akinobu Gotoh
Abstract There is no effective therapy for hormone‐refractory prostate cancer and a novel therapeutic modality, such as a gene therapy, should be actively pursued. Previously, Gardner and Chung conducted a phase I clinical trial of Ad‐OC‐TK (recombinant adenoviral vector containing osteocalcin promoter‐driven herpes simplex virus thymidine kinase gene) plus VAL (valacyclovir) for the treatment of hormone‐refractory prostate cancer at the University of Virginia. We report on our ongoing phase I/II clinical trial of Ad‐OC‐TK plus VAL for the treatment of advanced prostate cancer at the Kobe University Hospital, Japan.
Journal of Gene Medicine | 2004
Kazumasa Goda; Masato Fujisawa; Toshiro Shirakawa; Masaki Dobashi; Goshi Shiota; Zhu Jun Zhang; Akinobu Gotoh; Sadao Kamidono
Prior studies have shown that the hepatocyte growth factor (HGF), as known for its multiple biological effects, possibly regulates spermatogenesis or tubulogenesis in the testis. To clarify the effect of HGF on restoration of spermatogenesis, or testicular weight, we transferred the HGF gene into the testis of the rat experimental cryptorchid model.
International Journal of Urology | 2004
Kazumasa Goda; Gaku Kawabata; Tomihiko Yasufuku; Isao Hara; Masato Fujisawa; Sadao Kamidono; Hiroshi Okada
We describe a case of complete ureteral obstruction managed by endoscopic recanalization using a ‘cut‐to‐the‐light’ technique followed by potassium titanyl phosphate (KTP) laser ureterotomy. A 53‐year‐old man developed a ureteral obstruction following the transurethral resection of a bladder tumor (TUR‐Bt) at the left ureteral orifice. The length of the obstructed segment was estimated at 1 cm based on combined antegrade and retrograde contrast studies. Histopathological analysis indicated that the obstruction was caused by fibrosis. The ‘cut‐to‐the‐light’ technique was used for recanalization, and KTP laser ureterotomy was performed to obtain an adequate ureteral lumen. A 14 F/7 F endoureterotomy stent was removed 6 weeks after the operation. No significant complications and no signs of stenosis were observed 24 months after endoscopic repair. Endoscopic recanalization is a safe, effective technique for the management of a completely obliterated ureteral segment, especially in combination with subsequent KTP laser ureterotomy.
Fertility and Sterility | 2005
Hiroshi Okada; Kazumasa Goda; Yasuhisa Yamamoto; Nikolaos Sofikitis; Ikuo Miyagawa; Yasuyuki Mio; Mitsunobu Koshida; Shigeo Horie
Journal of Andrology | 2005
Tomomoto Ishikawa; Yutaka Kondo; Kazumasa Goda; Masato Fujisawa
Fertility and Sterility | 2005
Hiroshi Okada; Kazumasa Goda; Satoru Muto; Osamu Maruyama; Mitsunobu Koshida; Shigeo Horie
Fertility and Sterility | 2004
Hiroshi Okada; Toshiro Shirakawa; Tomomoto Ishikawa; Kazumasa Goda; Masato Fujisawa; Sadao Kamidono
Urology | 2007
Shuji Terao; Toshiro Shirakawa; Shuji Kubo; Acharya Bishunu; Sang-Jin Lee; Kazumasa Goda; Mamoru Tsukuda; Katsuyuki Hamada; Masatoshi Tagawa; Atsushi Takenaka; Masato Fujisawa; Akinobu Gotoh
Anticancer Research | 2005
Shuji Terao; Toshiro Shirakawa; Kazumasa Goda; Sadao Kamidono; Masato Fujisawa; Akinobu Gotoh
Asian Journal of Andrology | 2005
Masaki Dobashi; Kazumasa Goda; Hiroki Maruyama; Masato Fujisawa